Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Operating Leases: 2019-2025

Historic Operating Leases for Lifecore Biomedical (LFCR) over the last 5 years, with Feb 2025 value amounting to $5.4 million.

  • Lifecore Biomedical's Operating Leases rose 6.17% to $5.4 million in Q1 2025 from the same period last year, while for Feb 2025 it was $5.4 million, marking a year-over-year increase of 6.17%. This contributed to the annual value of $1.7 million for FY2024, which is 82.19% down from last year.
  • According to the latest figures from Q1 2025, Lifecore Biomedical's Operating Leases is $5.4 million, which was down 27.23% from $7.4 million recorded in Q4 2024.
  • Lifecore Biomedical's 5-year Operating Leases high stood at $17.9 million for Q1 2021, and its period low was $1.7 million during Q2 2024.
  • For the 3-year period, Lifecore Biomedical's Operating Leases averaged around $7.0 million, with its median value being $7.4 million (2024).
  • As far as peak fluctuations go, Lifecore Biomedical's Operating Leases soared by 32.96% in 2023, and later tumbled by 82.19% in 2024.
  • Quarterly analysis of 5 years shows Lifecore Biomedical's Operating Leases stood at $11.3 million in 2021, then tumbled by 38.12% to $7.0 million in 2022, then spiked by 32.96% to $9.3 million in 2023, then declined by 20.47% to $7.4 million in 2024, then increased by 6.17% to $5.4 million in 2025.
  • Its Operating Leases stands at $5.4 million for Q1 2025, versus $7.4 million for Q4 2024 and $4.8 million for Q3 2024.